Label: SIGNATURE CARE ACNE TREATMENT- salicylic acid liquid

  • NDC Code(s): 21130-722-48, 21130-722-77
  • Packager: SAFEWAY, INC.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 14, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients

    Salicylic Acid 2.0%

  • Purpose

    Acne Treatment

  • Uses

    for the treatment of acne.

  • Warnings

    For external use only

  • When using this product

    • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs only use one topical acne medication at a time. • avoid contact with eyes. If contact occurs, flush thoroughly with water.

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center immediately.

  • Directions

    • cover the entire affected area with a thin layer and rinse thoroughly one to three times daily
    • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
    • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • Other information

    • may stain some fabrics
  • Inactive Ingredients

    water, sodium C14-16 olefin sulfonate, cocamidopropyl betaine, chamomilla recutita (matricaria) flower extract, cocamidopropyl PG-dimonium chloride phosphate, propylene glycol, aloe barbadensis leaf juice, anthemis nobilis flower extract, C12-15 alkyl lactate, PEG-80 sorbitan laurate, disodium EDTA, benzalkonium chloride, fragrance, yellow 5, red 40.

  • Label

    SY70049E4F4

    SY32394EF

  • INGREDIENTS AND APPEARANCE
    SIGNATURE CARE ACNE TREATMENT 
    salicylic acid liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:21130-722
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALCOHOL (UNII: 3K9958V90M)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
    COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
    COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4)  
    PEG-80 SORBITAN LAURATE (UNII: 239B50Y732)  
    C12-15 ALKYL LACTATE (UNII: GC844VRD7E)  
    WATER (UNII: 059QF0KO0R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    CHAMAEMELUM NOBILE FLOWER (UNII: O2T154T6OG)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    CHAMOMILE (UNII: FGL3685T2X)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:21130-722-77177 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product03/26/2012
    2NDC:21130-722-48258 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product08/10/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02003/26/2012
    Labeler - SAFEWAY, INC. (009137209)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!